Trials / Completed
CompletedNCT03137901
Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring
Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Erasme University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study test the agreement and precision of Pulse Pressure Variation (PPV) and Cardiac Output (CO) obtained by the Android application Capstesia™ against another pulse contour CO monitoring ( EV-1000, Edwards Lefesciences, USA)
Detailed description
Pulse pressure variation (PPV) remains a good predictor of fluid responsiveness in the OR. However, PPV can be time-consuming to calculate (manual determination), is not always displayed on monitoring screens nor reliable through visual assessment and needs additional devices to be displayed. A new Android application (Captesia) automatically calculates the PPV utilizing a digital photograph of the arterial waveform from the monitor. The application determines the PPV by selecting peaks and troughs of the arterial curve.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Capstesia | Picture of the arterial waveform taken with a smartphone |
Timeline
- Start date
- 2017-05-10
- Primary completion
- 2017-06-30
- Completion
- 2017-06-30
- First posted
- 2017-05-03
- Last updated
- 2019-11-26
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03137901. Inclusion in this directory is not an endorsement.